Cytek biosciences earnings call
WebMar 31, 2024 · Cytek Biosciences now expects full year 2024 revenue to be closer to the high end of the range of $160 million to $168 million. Webcast Information Cytek will host a conference call to discuss the first quarter 2024 financial results on Wednesday, May 11, 2024, at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time. WebFeb 6, 2024 · Cytek Biosciences to Report Fourth Quarter and Full Year 2024 Financial Results on February 28, 2024. Feb 07, 2024.
Cytek biosciences earnings call
Did you know?
WebApr 13, 2024 · RBC Capital Markets is positief over het aandeel met een koopadvies. Voorheen was het koersdoel 579 USD, maar deze is licht aangepast naar 582 USD. 13 april 2024 WebApr 10, 2024 · Cytek Biosciences, Inc. is a cell analysis solutions company. The Company offers cell analysis tools by leveraging technical approaches. Its instruments, the Aurora and Northern Lights systems, are the spectrum flow cytometers able to deliver cell analysis by utilizing the spectrum of fluorescence signatures from multiple lasers to distinguish …
WebAug 10, 2024 · Cytek Biosciences, Inc. , which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $40.16 million for the quarter ended June 2024, missing the Zacks Consensus... WebFeb 28, 2024 · Cytek Biosciences, Inc., which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $48.34 million for the quarter ended December 2024, missing the Zacks...
WebMar 1, 2024 · Cytek Biosciences, Inc. (NASDAQ:NASDAQ:CTKB) Q4 and Full Year 2024 Earnings Conference Call February 28, 2024 4:30 PM ETCompany ParticipantsPaul … WebFeb 24, 2024 · Cytek Biosciences, Inc. (NASDAQ:NASDAQ:CTKB) Q4 2024 Earnings Conference Call February 23, 2024 5:00 PM ETCompany ParticipantsAlex Khan - …
WebMar 1, 2024 · Cytek Biosciences, Inc. (CTKB) delivered earnings and revenue surprises of 40% and 3.07%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
WebCytek Biosciences Fourth Quarter and Full Year 2024 Earnings Conference Call Cytek Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results Form 10-K … insight mission to mars nasaWebMar 31, 2024 · Cytek Biosciences - CTKB News Today $9.19 +0.28 (+3.14%) (As of 03/31/2024 12:00 AM ET) Compare Today's Range $8.95 $9.39 50-Day Range $8.44 $13.47 52-Week Range $7.38 $16.05 Volume 1.11 million shs Average Volume 737,749 shs Market Capitalization $1.24 billion P/E Ratio 459.73 Dividend Yield N/A Price Target … sbra investor relationsWeb哪里可以找行业研究报告?三个皮匠报告网的最新栏目每日会更新大量报告,包括行业研究报告、市场调研报告、行业分析报告、外文报告、会议报告、招股书、白皮书、世界500强企业分析报告以及券商报告等内容的更新,通过最新栏目,大家可以快速找到自己想要的内容。 insight mmrWebFeb 28, 2024 · 2024 Outlook. Cytek Biosciences expects full year 2024 revenue in the range of $225 million to $235 million, representing growth of 37% to 43% over full year 2024. This includes approximately $20 ... sbra legislative historyWebFeb 28, 2024 · Cytek Biosciences, Inc. provided revenue guidance for the full year 2024. For the year, the company expects revenue in the range of $225 million to $235 million, representing growth of 37% to 43% over full year 2024. This includes approximately $20 million of revenue contribution from the acquisition of Luminex's Flow Cytometry and … sbra stock price today nyseWebNov 8, 2024 · Cytek Biosciences, Inc. (NASDAQ:CTKB) Q3 2024 Earnings Conference Call November 8, 2024 4:30 PM ET. Company Participants. Wenbin Jiang - Chief … sbran1231 hotmail.comWebMay 11, 2024 · Presentation Operator MessageOperator Thank you for standing by, and welcome to the Cytek Biosciences First Quarter 2024 Earnings Conference Call. [Operator Instructions] As a reminder, today's... April 12, 2024 insight mobile banking balance